| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.12T | 847.55B | 793.26B | 711.81B | 682.91B |
| Gross Profit | 163.97B | 108.84B | 105.90B | 92.07B | 84.86B |
| EBITDA | 114.41B | 82.50B | 83.34B | 79.46B | 69.13B |
| Net Income | 76.57B | 32.42B | 32.57B | 33.49B | 26.69B |
Balance Sheet | |||||
| Total Assets | 2.02T | 1.45T | 1.41T | 978.06B | 926.43B |
| Cash, Cash Equivalents and Short-Term Investments | 360.98B | 119.50B | 113.42B | 91.94B | 78.06B |
| Total Debt | 612.97B | 418.68B | 504.28B | 189.91B | 194.17B |
| Total Liabilities | 1.38T | 907.88B | 991.38B | 603.97B | 570.56B |
| Stockholders Equity | 610.60B | 519.14B | 399.92B | 361.78B | 346.91B |
Cash Flow | |||||
| Free Cash Flow | 139.99B | 1.75B | -3.85B | 62.93B | -38.03B |
| Operating Cash Flow | 192.78B | 39.60B | 38.92B | 102.76B | -16.33B |
| Investing Cash Flow | -39.25B | -23.94B | -279.25B | -22.08B | -22.55B |
| Financing Cash Flow | 86.67B | -8.44B | 261.32B | -67.80B | 15.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥589.87B | 7.35 | ― | 2.89% | 32.72% | 133.48% | |
79 Outperform | ¥620.87B | 17.24 | 8.34% | 2.66% | 2.61% | 22.78% | |
78 Outperform | ¥1.32T | 20.88 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥648.88B | 16.43 | ― | 2.15% | 0.46% | 38.67% | |
72 Outperform | ¥561.38B | 18.94 | ― | 2.51% | 17.43% | 16.94% | |
70 Neutral | ¥326.08B | 14.94 | 8.70% | 2.28% | 4.11% | 37.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |